| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:512598630:1914 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:512598630:1914?format=raw |
LEADER: 01914cam a2200433 a 4500
001 3956701
005 20221027005802.0
008 910416s1984 nyua b 101 0 eng
010 $a 84017898
020 $a0890049556
035 $a(OCoLC)11114290
035 $a(OCoLC)ocm11114290
035 $a(CStRLIN)NYCM91-B1935
035 $9AFC8747HS
035 $a(NNC)3956701
035 $a3956701
040 $dCStRLIN
050 00 $aRC692$b.A729 vol. 12
060 0 $aW1 AT385 v. 12$aWG 166 E56 1983
082 0 $a616.1/36 s$a616.1/061$219
245 00 $aEnd points for cardiovascular drug studies /$ceditor, Ruth Johnsson Hegyeli.
260 $aNew York :$bRaven Press,$c1984.
300 $axiii, 200 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAtherosclerosis reviews ;$vv. 12
504 $aIncludes bibliographical references and index.
650 0 $aAtherosclerosis$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2009116134
650 0 $aAtherosclerosis$xChemotherapy$vCongresses.
650 0 $aCardiovascular agents$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2009118148
650 2 $aCardiovascular Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D002318Q000188
650 2 $aCardiovascular Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D002317Q000494
650 2 $aCardiovascular Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D002317Q000627
650 2 $aArteriosclerosis$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D001161Q000175
650 2 $aUltrasonography.$0https://id.nlm.nih.gov/mesh/D014463
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aHegyeli, Ruth Johnsson,$d1931-$0http://id.loc.gov/authorities/names/n81009488
830 0 $aAtherosclerosis reviews ;$vv. 12.$0http://id.loc.gov/authorities/names/n42002845
852 80 $boff,hsr$hSerial$iA